6076 - 6100 of 8666 Results
Title
Year
-
OPENTitle: SymposiaJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: S1Start Page: 6End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.15461Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15461Citation Count: 2
-
OPENTitle: An efficient and scalable synthesis of thiazolo ring fused 2-pyridones using flow chemistryJournal Name: ArkivocPublisher: ARKAT USA, Inc.Vol: 2020Issue #: 7Start Page: 365End Page: 378Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.24820/ark.5550190.p011.445Best OA location URL: https://www.arkat-usa.org/get-file/72918/Citation Count: 0
- Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis2021OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10391001/pdf/jmcp.2021.27.6.785.pdfCitation Count: 10
- Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learning2021OPENTitle: Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learningJournal Name: Quantitative Imaging in Medicine and SurgeryPublisher: AME Publishing CompanyVol: 12Issue #: 2Start Page: 906End Page: 919Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/qims-21-425Best OA location URL: https://qims.amegroups.com/article/viewFile/78913/pdfCitation Count: 29
- Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition2020OPENTitle: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase InhibitionJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 20Issue #: 1Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259Best OA location URL: https://aacrjournals.org/mct/article-pdf/20/1/64/1866868/64.pdfCitation Count: 13
-
RESTRICTEDTitle: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulationJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6564Start Page: 201End Page: 206Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abi7852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11098594Citation Count: 127
-
OPENTitle: CD4 + T cells contribute to neurodegeneration in Lewy body dementiaJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6569Start Page: 868End Page: 874Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abf7266Best OA location URL: https://escholarship.org/uc/item/7h341961Citation Count: 172
- Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity2022OPENTitle: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicityJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 9Start Page: 1134End Page: 1148Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01140-3Best OA location URL: https://www.nature.com/articles/s41593-022-01140-3.pdfCitation Count: 172
- Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial2024OPENTitle: Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 12Start Page: 3669End Page: 3675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03270-6Best OA location URL: https://doi.org/10.1038/s41591-024-03270-6Citation Count: 18
- PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain2022OPENTitle: PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domainJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 479Issue #: 18Start Page: 1941End Page: 1965Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20220308Best OA location URL: https://portlandpress.com/biochemj/article-pdf/479/18/1941/937618/bcj-2022-0308.pdfCitation Count: 10
- White matter microstructural characteristics in newly diagnosed Parkinson’s disease: An unbiased whole-brain study2016OPENTitle: White matter microstructural characteristics in newly diagnosed Parkinson’s disease: An unbiased whole-brain studyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep35601Best OA location URL: https://www.nature.com/articles/srep35601.pdfCitation Count: 44
-
OPENTitle: In situ architecture of the lipid transport protein VPS13C at ER–lysosome membrane contactsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 29Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1073/pnas.2203769119Best OA location URL: https://doi.org/10.1073/pnas.2203769119Citation Count: 62
- State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease2023OPENTitle: State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's diseaseJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12376Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12376Citation Count: 9
-
OPENTitle: Sex differences in associations between APOE ε2 and longitudinal cognitive declineJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 10Start Page: 4651End Page: 4661Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.13036Best OA location URL: https://escholarship.org/uc/item/7cg3k6z5Citation Count: 12
- Single‐cell sequencing of entorhinal cortex reveals widespread disruption of neuropeptide networks in Alzheimer's disease2023OPENTitle: Single‐cell sequencing of entorhinal cortex reveals widespread disruption of neuropeptide networks in Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 8Start Page: 3575End Page: 3592Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12979Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12979Citation Count: 6
- Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel2023OPENTitle: Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panelJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12375Best OA location URL: https://escholarship.org/uc/item/12q8s9x7Citation Count: 12
- Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review2023OPENTitle: Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart reviewJournal Name: Epilepsia OpenPublisher: WileyVol: 8Issue #: 2Start Page: 371End Page: 385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12695Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/epi4.12695Citation Count: 7
-
OPENTitle: Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 907End Page: 909Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29399Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29399Citation Count: 6
-
OPENTitle: The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 4Start Page: 596End Page: 605Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13678Best OA location URL: https://escholarship.org/uc/item/2wb861ndCitation Count: 1
- Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease2023OPENTitle: Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 896End Page: 902Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13726Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13726Citation Count: 1
-
OPENTitle: Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 933End Page: 942Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13747Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10272891Citation Count: 1
- Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging2021OPENTitle: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on AgingJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 18Issue #: 2Start Page: 345End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.9562Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8804990Citation Count: 11
-
OPENTitle: Unveiling the B cell receptor structureJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 819End Page: 820Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add8065Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11044948Citation Count: 10
- Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites2022OPENTitle: Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolitesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 378Issue #: 6618Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abm3233Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9993714Citation Count: 165
- Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma2022OPENTitle: Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in OsteosarcomaJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 21Issue #: 6Start Page: 903End Page: 913Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1158/1535-7163.mct-21-0836Best OA location URL: https://aacrjournals.org/mct/article-pdf/21/6/903/3191485/903.pdfCitation Count: 27